Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADHD
Marketing
PMCPA sanctions melatonin drugmaker over misleading information
The U.K. pharma marketing watchdog slammed AGB Pharma for misleadingly implying a lack of fertility considerations for its melatonin drug, Adaflex.
Nick Paul Taylor
Jul 29, 2026 7:20am
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
Jul 27, 2026 12:42pm
Corium sells off ADHD drug Azstarys to Collegium for $650M-plus
Mar 19, 2026 11:27am
Collegium enrolls Paris Hilton in Jornay PM ADHD campaign
Mar 4, 2026 3:33pm
Otsuka awareness campaign urges HCPs to see 'All of ADHD'
Feb 9, 2026 12:22pm
Pfizer, Tris settle ADHD drug claims with $41.5M in Texas
Nov 20, 2025 11:35am
